Subscribe and listen to Tech & Science Daily here: [ Ссылка ]
Scientists say the technology used in the Oxford-AstraZeneca COVID jab has been applied to design a vaccine that could help treat cancer by targeting tumours in humans.
We spoke to Professor Benoit Van den Eynde, Professor of Tumour Immunology at Oxford University, who explains how the potential cancer vaccine would work.
Subscribe to the Evening Standard on YouTube: [ Ссылка ]
